Clinical Trial

PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection

Study acronym: PERSEVERE
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, non-randomized, multicenter clinical investigation to assess the safety and effectiveness of AMDS in the treatment of patients with acute DeBakey type I dissection, with evidence of malperfusion, through open surgical repair.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2021-12-13; most recent amendment 2025-01-13.
Status change: Recruiting → Active, Not Recruiting 2025-01-13
Status change: Active, Not Recruiting → Recruiting 2024-08-23
Status change: Recruiting → Active, Not Recruiting 2024-08-14
Status change: Not Yet Recruiting → Recruiting 2022-07-07
Trial Details
NCT Number NCT05174767
Lead Sponsor Artivion Inc.
Collaborators: Syneos Health
Conditions Acute Aortic Dissection
Enrollment 115 participants
Start Date 2022-05-27
Primary Completion 2023-12-11 (estimated)
Study Completion 2029-12-06 (estimated)
Updated on ClinicalTrials.gov 2025-01-15